REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
15/09/2025
Voltar para busca
Dado oficial do USPTO
PLEXPCR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
16/09/2025
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
17/06/2019
Data de registro
15/09/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/09/2020
Última transação
16/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
MASON,JARED MICHAEL
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SpeeDx Pty Ltd
Representantes
Joi A. White Carr & Ferrell LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus; design of diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation services for scientific testing and research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation services for scientific testing and research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific testing and research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsrelating to the results of scientific and medical experiments and testsrelating to the analysis and evaluation of scientific and medical datarelating to data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays
Classe 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; molecular diagnostics testing for medical purposes; providing collected and analysed medical information in the field of genetics and providing medical treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2021
FIMP
FINAL DISPOSITION PROCESSED
05/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
15/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/06/2020
PUBO
PUBLISHED FOR OPPOSITION
30/06/2020
GPNX
NOTIFICATION PROCESSED BY IB
26/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/06/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/12/2019
RFNT
REFUSAL PROCESSED BY IB
06/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/11/2019
RFRR
REFUSAL PROCESSED BY MPU
19/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
26/10/2019
CNRT
NON-FINAL ACTION WRITTEN
25/10/2019
DOCK
ASSIGNED TO EXAMINER
22/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PLEXPCR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.